THE TOP 4 REASONS EXECUTIVES NEED TO TAKE ANALYTIC OPERATIONS SERIOUSLY
1. BRAND STRATEGIES AND EXECUTION ARE NOT REACHING THEIR FULL POTENTIAL - If your data scientists are spending all their time manually running existing models two things are happening. First, the frequency of insights delivered to the business is greatly diminished. If you can only run customer preference analytics once every two months on month old data, the insights are stale. Promotional effectiveness from disease state awareness to voucher programs will suffer. Second, far fewer new insights are being generated. It is the “new” that disrupts business and drives competitive advantage. Imagine the opportunity cost associated with a novel model that better predicts patient starts: if it is not in production, it is not adding value to the business.
2. SPENDING MORE MONEY THAN NECESSARY - Data scientists are expensive. You do not need a cadre of PhDs to run existing models. Costs can be cut through operational automation.
3. COMPETITIVE ADVANTAGE KNOWLEDGE IS BEING LOST - When data scientists leave or take roles elsewhere internally, there is a risk that all of the knowledge about data integration and the model algorithms will leave as well. It is very hard to successfully take over a complex model where there are no standards or documentation.
4. MAKING DECISIONS BASED ON BAD INFORMATION - Manual processes are highly error prone. Without rigorous automated checks, it is very likely that a mistake in the data or the model will go unnoticed and the corresponding insights will be flawed.
----
SENTIER was founded in 2017 to disrupt analytic insight generation and delivery in Pharma. Through VELOCITY, the industry leading Analytic Operations as a Service (AOaaS) platform, our customers are able to maximize the ROI on AI and ML activities by allowing non-data scientists to deliver answers as frequently as the business demands. We also support our clients with advanced marketing & sales analytics and support services designed to prepare models and data pipelines for production. SENTIER believes that the ethical application of solutions will benefit patients and health care providers as well as the Pharma and Biotech companies we work with.
